| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 04/29/1997 | US5624795 Isolation and characterization of a novel chimpanzee lentivirus, designated simian immunodeficiency virus isolate cpz-ant |
| 04/28/1997 | CA2185407A1 Sustainable chick cell line infected with marek's disease virus |
| 04/28/1997 | CA2185406A1 Improvements in sustainable cell line for the production of marek's disease vaccines |
| 04/24/1997 | WO1997014802A1 Novel adherence factors of non pathogenic microorganisms and applications thereof for screening microorganisms for specific probiotic properties; novel pharmaceutical compositions and food additives comprising such microorganisms and adherence factors |
| 04/24/1997 | WO1997014801A1 Novel cell surface protein compounds |
| 04/24/1997 | WO1997014800A1 Novel saliva binding protein |
| 04/24/1997 | WO1997014799A1 Fibronectic binding protein b compounds |
| 04/24/1997 | WO1997014716A1 Cyclopeptide derivatives |
| 04/24/1997 | WO1997014713A1 Amphiphilic complexes, method for preparing same and compositions containing such complexes |
| 04/24/1997 | WO1997014690A1 5-(acetamidomethyl)-3-aryldihydrofuran-2-one and tetrahydrofuran-2-one derivatives with antibiotic activity |
| 04/24/1997 | WO1997014683A2 Phenanthridine derivatives, methods of producing them and medicaments containing phenanthridine derivatives |
| 04/24/1997 | WO1997014442A1 Hormone immunomodulated induction of mucosal immune responses |
| 04/24/1997 | WO1997014436A1 Synthetic vaccine for protection against human immunodeficiency virus infection |
| 04/24/1997 | WO1997014434A1 Influenza vaccine |
| 04/24/1997 | WO1997014433A1 Chicken interleukin-15 and uses thereof |
| 04/24/1997 | WO1997014421A1 Namenamicin, an enediyne antitumor antibiotic from the marine ascidian polysyncraton lithostrotum |
| 04/24/1997 | WO1997014410A1 Lipid alcohols as new immunosuppressive and antiviral drugs |
| 04/24/1997 | WO1996038474A3 Diagnosis of, and vaccination against, a positive stranded RNA virus using an isolated, unprocessed polypeptide |
| 04/24/1997 | WO1996034107A3 Antiviral proteins, dna coding sequences therefor, and uses thereof |
| 04/24/1997 | DE19538741A1 Cyclopeptidderivate Cyclopeptide derivatives |
| 04/24/1997 | CA2235257A1 Influenza vaccine |
| 04/24/1997 | CA2235168A1 Synthetic vaccine for protection against human immunodeficiency virus infection |
| 04/24/1997 | CA2234244A1 Lipid alcohols as new immunosuppressive and antiviral pharmaceutical agents |
| 04/24/1997 | CA2232609A1 Phenanthridine derivatives, methods of producing them and medicaments containing phenanthridine derivatives |
| 04/23/1997 | EP0769056A1 NON-SPLICING VARIANTS OF gp350/220 |
| 04/23/1997 | EP0769054A1 Immunomodulators |
| 04/23/1997 | EP0769019A1 Helicobacter pylori antigenic protein preparation and immunoassays |
| 04/23/1997 | EP0769018A1 Helicobacter proteins and vaccines |
| 04/23/1997 | EP0769017A1 Therapeutic compounds |
| 04/23/1997 | EP0768894A1 Multi-stage cascade boosting vaccine |
| 04/23/1997 | EP0768893A1 Polynucleotide vaccine for papillomavirus |
| 04/23/1997 | EP0768887A1 Compositions having antiviral properties and preparation process |
| 04/23/1997 | EP0768881A2 Anti-hiv triple combination |
| 04/23/1997 | EP0768874A1 Pharmaceutical compositions containing Triclosan or derivates thereof and Edta or Egta |
| 04/23/1997 | EP0768819A1 Combined virustatic antimediator (covam) treatment of common colds |
| 04/23/1997 | EP0654036B1 Liponucleotides of seco-nucleosides, their preparation and their use as anti-viral drugs |
| 04/23/1997 | EP0651754B1 K-252a DERIVATIVES |
| 04/23/1997 | EP0637243B1 Novel aminosterol antibiotic |
| 04/23/1997 | EP0563249B1 Targeting of therapeutic agents using polysaccharides |
| 04/23/1997 | EP0550477B1 Inactivated mycoplasma hyopneumoniae bacterin and method of use thereof |
| 04/23/1997 | CN1148393A Bradykinin antagonist peptides incorporating N-substituted glycines |
| 04/23/1997 | CN1148391A Increased bioavailability of biologically active compounds by linking to polypyrrolecarboxamido-naphthalene derivatives |
| 04/23/1997 | CN1148387A Substd. aminoalkylaminopyridine |
| 04/23/1997 | CN1148344A New oral pharmaceutical dosage form |
| 04/23/1997 | CN1148339A Thiadiazoles and their use as antipicornaviral agent |
| 04/23/1997 | CN1148047A Derivatives of 12,13-epoxy-tylosin and processes of mfr. thereof |
| 04/23/1997 | CN1148042A New heterocyclically substituted pseudopeptides |
| 04/23/1997 | CN1034663C Method for preparing hemoregulatory peptides |
| 04/22/1997 | US5623081 Method for producing tetrahydrofuranyl compounds |
| 04/22/1997 | US5623049 Flexible antisense agents comprising oligonuceotides having the (deoxy)ribose backbone replaced by an oligopeptide; protease- and nuclease-resistant; viricides; attached to carriers able to penetratate in cells |
| 04/22/1997 | US5622963 Innovative technique for immunosuppression involving administration of rapamycin loaded formed blood elements |
| 04/22/1997 | US5622939 Glucan preparation |
| 04/22/1997 | US5622933 Multiple branch peptide constructions for use against HIV |
| 04/22/1997 | US5622848 Electrically hydrolyzed salines as microbiocides for in vitro treatment of contaminated fluids containing blood |
| 04/22/1997 | US5622724 Spraying aqueous or saline solution containing zinc sulfate or zinc chloride to the nostrils or respiratory track of a patient suffering from common cold |
| 04/22/1997 | US5622706 Synthetic polypeptide comprising amino acid sequence of mature stx gene; accellular vaccines |
| 04/22/1997 | US5622701 Provides monoclonal antibodies that have binding site that specifically binds to p-selectin and to e-selectin |
| 04/22/1997 | CA2015235C Povidone-iodine neonatal ophthalmic antimicrobial prophylactic agent |
| 04/17/1997 | WO1997013861A1 Composition and method of imparting resistivity to hiv superinfection to cells |
| 04/17/1997 | WO1997013860A1 Neisseria meningitidis subunit tbp2 |
| 04/17/1997 | WO1997013856A1 Improvements in or relating to protection against intracellular infection |
| 04/17/1997 | WO1997013845A2 Phosphopantetheinyl transferases and uses thereof |
| 04/17/1997 | WO1997013785A1 Transferrin receptor protein of moraxella |
| 04/17/1997 | WO1997013784A1 Helicobacter lactoferrin receptor |
| 04/17/1997 | WO1997013777A1 Novel orthosomycins from micromonospora carbonacea |
| 04/17/1997 | WO1997013772A2 Cephalosporin antibiotics |
| 04/17/1997 | WO1997013529A1 Immunotoxin containing a disulfide-stabilized antibody fragment |
| 04/17/1997 | WO1997013527A1 Treatments of helicobacter pylori infections |
| 04/17/1997 | WO1997013523A1 Swine immunization using live, rtx toxin-secreting organisms |
| 04/17/1997 | WO1997013511A1 Methods of inhibiting plasminogen activator inhibitor 1 |
| 04/17/1997 | WO1997013506A1 η-RAR ANTAGONIST LIGAND OR α-RAR AGONIST LIGAND AS AN APOPTOSIS INHIBITOR |
| 04/17/1997 | WO1997013505A2 USE OF A η-RAR-SPECIFIC AGONIST LIGAND TO INCREASE APOPTOSIS RATE |
| 04/17/1997 | WO1997013495A1 Antimicrobial compositions containing a c3-c6 alcohol |
| 04/17/1997 | WO1997005870A3 Use of griseofulvin for inhibiting the growth of cancers |
| 04/17/1997 | WO1997005864A3 Use of l-carnitine and derivatives for reducing ceramide levels and potentiating antiretroviral drugs |
| 04/17/1997 | DE19545139C1 Use of 1-hydroxy-pyridone cpds. to control yeast and fungi |
| 04/17/1997 | DE19538402A1 Lipidalkohole als neue immunsuppressive und antivirale Arzneimittel Lipid alcohols as new immunosuppressive and antiviral drugs |
| 04/17/1997 | DE19538088A1 Phenanthridinderivate und ihre Herstellung Phenanthridine derivatives and their preparation |
| 04/17/1997 | CA2234666A1 Immunotoxin containing a disulfide-stabilized antibody fragment |
| 04/17/1997 | CA2234404A1 Methods of inhibiting plasminogen activator inhibitor 1 |
| 04/17/1997 | CA2234255A1 Cephalosporin antibiotics |
| 04/17/1997 | CA2232640A1 Antimicrobial compositions containing a c3-c6 alcohol |
| 04/17/1997 | CA2232155A1 Improvements in or relating to protection against intracellular infection |
| 04/17/1997 | CA2231561A1 Use of a .gamma.-rar-specific agonist ligand to increase apoptosis rate |
| 04/17/1997 | CA2207302A1 Neisseria meningitidis subunit tbp2 |
| 04/17/1997 | CA2187850A1 Physiologically active ei-1941 compounds |
| 04/16/1997 | EP0768312A2 Bis-Staurosporine and K-252a derivatives |
| 04/16/1997 | EP0768308A1 New derivatives of pyroglutaminic acid, preparation process and applications |
| 04/16/1997 | EP0768306A1 Physiologically active hydrogenated benzopyran compounds |
| 04/16/1997 | EP0768085A1 Antibacterial agent |
| 04/16/1997 | EP0767796A1 Monocyte chemotactic protein-4 |
| 04/16/1997 | EP0767793A1 N-substituted-(dihydroxyboryl)alkyl purine, indole and pyrimidine derivatives, useful as inhibitors of inflammatory cytokines |
| 04/16/1997 | EP0767677A1 Electrically hydrolyzed salines as in vivo microbicides for the treatment of cardiomyopathy and multiple sclerosis |
| 04/16/1997 | EP0767671A1 Method of combating acyclovir-resistant herpes simplex viral infections |
| 04/16/1997 | EP0767667A2 USE OF $g(b)GalNac(1-4)$g(b)Gal CONJUGATES TO TREAT CANDIDA INFECTION |
| 04/16/1997 | EP0767664A2 Combination therapy for hiv infection |
| 04/16/1997 | EP0767657A1 Novel method of preparation of known and novel 2'-modified nucleosides by intramolecular nucleophilic displacement |
| 04/16/1997 | EP0708770B1 Amide derivatives of 16-membered ring antibiotic macrolides |
| 04/16/1997 | EP0497978B1 Cephalosporin compounds and production thereof |
| 04/16/1997 | CN1147834A Coordinate in vivo gene expression |